CoreLink Announces the Acquisition of Medical Device Company Expanding Orthopedics, Inc.

Prevail Drug Coated Balloon Catheter Launches in Europe

Prevail Drug coated balloon catheter is used during percutaneous coronary intervention procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease.

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

June 5, 2018

CoreLink, LLC, a fast-growing, vertically integrated designer and manufacturer of spinal implant systems, announced today the acquisition of the privately-held Israeli medical device company Expanding Orthopedics, Inc (EOI).

CoreLink adds along with the FDA cleared expanding and articulating FLXfit™ and FLXfit 15™ titanium TLIF interbody systems, CoreLink has also acquired a broad array of patents and in-development products addressing the expandable interbody and spinal fusion market.

“This acquisition provides two key benefits for CoreLink and its customers: a very compelling offering in the growing expandable interbody product category and a portfolio of innovative intellectual property from which we can advance spine care,” commented Jay Bartling, CEO of CoreLink. “Combining these assets with CoreLink’s unique in-house design and manufacturing capabilities provides tremendous opportunities for us and our business partners.”

FLXfit 15 is an unique titanium TLIF interbody device compatible with Minimally Invasive Surgery. Once in the disc space, it articulates to aid placement along the anterior aspect of the apophyseal ring, providing up to 40mm of footprint length along this critical anterior column. The anterior height of the device can be continuously expanded an additional 4mm to provide up to 15° of lordosis. CoreLink will provide enhanced support for existing users of both the FLXfit and FLXfit 15 systems, while utilizing its unique vertical integration to quickly incorporate system upgrades for a full commercial re-launch in Q3.

“This is an exciting time for product development at CoreLink,” said David Castleman, VP of Research and Development. “There is great opportunity here to leverage the EOI expandable technology across several product categories, from other interbody applications to pedicle screw solutions.”

spot_img

DON'T MISS

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.